287 related articles for article (PubMed ID: 10590913)
1. Use of leukotriene antagonists in childhood asthma.
Krawiec ME; Wenzel SE
Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
3. Antileukotrienes in asthma: present situation.
García-Marcos L; Schuster A
Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
[TBL] [Abstract][Full Text] [Related]
4. Asthma treatment: antileukotriene drugs.
O'Byrne PM
Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
[TBL] [Abstract][Full Text] [Related]
5. New perspectives for asthma treatment: anti-leukotriene drugs.
García-Marcos L; Schuster A
Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
[TBL] [Abstract][Full Text] [Related]
6. The role of antileukotrienes in asthma management.
Tan RA
Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
Spahr JE; Krawiec ME
Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
[TBL] [Abstract][Full Text] [Related]
8. [Antileukotrienes in the therapy of bronchial asthma].
Riccioni G; Della Vecchia R; Menna V; Lambo MS; Di Ilio C; D'Orazio N
Recenti Prog Med; 2003 Nov; 94(11):509-15. PubMed ID: 14679921
[TBL] [Abstract][Full Text] [Related]
9. Antileukotriene agents in asthma: the dart that kills the elephant?
Renzi PM
CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
[TBL] [Abstract][Full Text] [Related]
10. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
11. New treatments for asthma: the role of leukotriene modifier agents.
Valacer DJ
J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic advances: leukotriene antagonists for the treatment of asthma.
Misson J; Clark W; Kendall MJ
J Clin Pharm Ther; 1999 Feb; 24(1):17-22. PubMed ID: 10319903
[TBL] [Abstract][Full Text] [Related]
13. Critical appraisal of antileukotriene use in asthma management.
Polosa R
Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
[TBL] [Abstract][Full Text] [Related]
14. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.
Warner JO
Allergy; 2001; 56 Suppl 66():22-9. PubMed ID: 11421938
[TBL] [Abstract][Full Text] [Related]
15. Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma.
Dahlén SE
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():141-6; discussion 171-3. PubMed ID: 9988460
[TBL] [Abstract][Full Text] [Related]
16. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
17. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
Claesson HE; Dahlén SE
J Intern Med; 1999 Mar; 245(3):205-27. PubMed ID: 10205583
[TBL] [Abstract][Full Text] [Related]
18. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors].
Henriksen AH; Bjermer L
Tidsskr Nor Laegeforen; 1997 Feb; 117(5):647-51. PubMed ID: 9102953
[TBL] [Abstract][Full Text] [Related]
19. Montelukast in childhood asthma: what is the evidence for its use?
Amlani S; McIvor RA
Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
[TBL] [Abstract][Full Text] [Related]
20. Antileukotriene agents.
Tan RA; Spector SL
Curr Opin Pulm Med; 1997 May; 3(3):215-20. PubMed ID: 9232368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]